Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 2020-Reference-Cited by-同舟云学术

Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 2020

Published:2021 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kim Hyoeun¹,Lee Chan Joo²,Kim Sang-Hyun³,Kim Jang Young⁴,Choi Sung Hee⁵,Kang Hyun-Jae⁶,Park Kyong Soo⁶,Cho Byung Ryul⁷,Kim Byung Jin⁸,Sung Ki Chul⁸,Jeong In-Kyung⁹,Jeong Jin-Ok¹⁰,Bae Jang-Whan¹¹,Park Jung Mi¹²,Lee Yunbeom¹³,Jeong Ilecheon¹³,Han Hyojun¹³,Lee Ji Hyun¹⁴,Lee Sang-Hak²,

Affiliation:

1. Department of Health Promotion, Yonsei University Health System

2. Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine

3. Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine

4. Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine

5. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine

6. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine

7. Cardiology Division, Department of Internal Medicine, Kangwon National University, School of Medicine

8. Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine

9. Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine

10. Department of Internal Medicine, Cardiovascular Center, Chungnam National University Hospital, Chungnam National University School of Medicine

11. Department of Internal Medicine, Chungbuk National University College of Medicine

12. Department of Biostatistics and Computing, Yonsei University Graduate School

13. Celemics Inc.

14. Department of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_63062/_pdf

Reference25 articles.

1. 1) Stock, J: Familial hypercholesterolemia: an urgent public health priority. Atherosclerosis, 2020; 308: 48-49

2. 2) Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK; Committee of Clinical Practice Guideline of Korean Society of Lipid and Atherosclerosis: 2018 guidelines for the management of dyslipidemia in Korea. J Lipid Atheroscler, 2019; 8: 78-131

3. 3) Choi JY and Na JO: Pharmacological strategies beyond statins: ezetimibe and PCSK9 inhibitors. J Lipid Atheroscler, 2019; 8: 183-191

4. 4) Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies: 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis, 2019; 290: 140-205

5. 5) Benn M, Watts GF, Tybjærg-Hansen A, and Nordestgaard BG: Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Eur Heart J, 2016; 37(17): 1384-1394

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calling and Phasing of Single-Nucleotide and Structural Variants of the LDLR Gene Using Oxford Nanopore MinION;International Journal of Molecular Sciences;2023-02-24

2. 2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea;The Korean Journal of Medicine;2022-12-01

3. 2022 Consensus statement on the management of familial hypercholesterolemia in Korea;The Korean Journal of Internal Medicine;2022-09-01